Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data ...

On a recent episode of Bloomberg's China Show, David (Jingfeng) Huang, Founder, Chairman and CEO of Yatsen Holding Ltd. (NYSE ...

The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

Reckitt Benckiser's CEO, Kris Licht, highlighted India as a key growth driver, anticipating sustained strong volume growth ...